Pfizer PFE
NYSE PFE
$30.24 +0.39 (+1.31%)
As of: Oct 22, 2026 · 11:57 AM EDT

Pfizer (PFE) Land & Improvements (2009 - 2011)

Updated

Pfizer (PFE) posted Land & Improvements of $747 million for Q4 2011, down 5.6% from $791 million a year earlier.

Analysis

Pfizer (PFE) Land & Improvements (2009 - 2011) Analysis & Trends

  • In prior years, Pfizer's Land & Improvements was $791 million in FY2010 (-15.6%) and $937 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Land & Improvements (Qtr)
1 Eli Lilly 1,170.86 Bn 1,139.45 Bn 19.71 Bn -
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn -
3 AbbVie 501.68 Bn 474.79 Bn 12.70 Bn -
4 Merck 374.79 Bn 329.16 Bn 12.21 Bn -
5 Novartis Ag 302.69 Bn 266.68 Bn 11.24 Bn -
6 Astrazeneca 268.27 Bn 241.96 Bn 12.86 Bn -
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn -
8 Gilead Sciences 193.38 Bn 167.58 Bn 6.22 Bn -
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 136.26 Bn 108.27 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 747.00 Mn
Dec 31, 2010 791.00 Mn
Dec 31, 2009 937.00 Mn
API Access

Pfizer Land & Improvements API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=land-and-improvements&ticker=PFE&period=max&api_key=YOUR_API_KEY